Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hand hygiene01:23

Hand hygiene

6.4K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
6.4K
Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

1.1K
Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
1.1K
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

1.1K
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
1.1K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.6K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.6K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

941
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
941
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

6.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time to Meaningful Clinical Response Across Approved and Emerging Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Network Meta-Analysis.

Journal of clinical medicine·2026
Same author

Response to Commentary: Aligning Dermatology Continuing Certification and Quality Outcomes Through Research.

Journal of the American Academy of Dermatology·2026
Same author

Intravenous extravasation report generation using deep learning, generative artificial intelligence, and visual question answering techniques.

Scientific reports·2026
Same author

Retirement Patterns in Mohs Micrographic Surgeons and General Dermatologists: A Medicare Part B and Part D Analysis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Mandatory recertification and practice patterns of dermatologists: A Medicare Part B and Part D Database analysis.

Journal of the American Academy of Dermatology·2026
Same author

Reply to Torres et al, "Reply to Woodie et al, 'Elevated risk of active tuberculosis with interleukin-17, interleukin-23, interleukin-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX'".

Journal of the American Academy of Dermatology·2026
Same journal

Microblading Technique for Tattooing of "Hairstrokes" That Simulate Natural Hair: Eyebrow Tattooing and Correction of Medical Conditions.

Current problems in dermatology·2023
Same journal

Preface.

Current problems in dermatology·2023
Same journal

On the Use, Effectiveness, and Safety of Face Masks, Gloves, and Disinfectants to Prevent Transfer of Microbials between the Tattooist and the Customer: A Practical Review of Pros and Cons Including the Occupational Safety of the Tattooist.

Current problems in dermatology·2023
Same journal

Linearity and Surface Anatomy of the Face: From Embryo to Senescence.

Current problems in dermatology·2023
Same journal

Stretch Mark Treatment by Tattooing and Microneedling.

Current problems in dermatology·2023
Same journal

Auxiliary Utensils in Cosmetic and Medical Tattoo Settings.

Current problems in dermatology·2023
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

13.2K

Itch Management: Systemic Agents.

Padcha Pongcharoen, Alan B Fleischer

    Current Problems in Dermatology
    |September 1, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Itch is a complex global health issue. This review summarizes systemic treatments for chronic itch, focusing on agents targeting underlying causes for better patient outcomes.

    More Related Videos

    A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
    08:02

    A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

    Published on: March 24, 2023

    5.2K
    Murine Model of Epicutaneously-Induced Immunomodulation
    09:07

    Murine Model of Epicutaneously-Induced Immunomodulation

    Published on: June 24, 2025

    616

    Related Experiment Videos

    Last Updated: Mar 15, 2026

    Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
    04:59

    Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

    Published on: September 27, 2019

    13.2K
    A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
    08:02

    A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

    Published on: March 24, 2023

    5.2K
    Murine Model of Epicutaneously-Induced Immunomodulation
    09:07

    Murine Model of Epicutaneously-Induced Immunomodulation

    Published on: June 24, 2025

    616

    Area of Science:

    • Dermatology
    • Clinical Medicine
    • Pharmacology

    Background:

    • Itch (pruritus) is a widespread clinical problem with complex underlying causes.
    • Effective treatment is challenging due to the intricate pathophysiology of itch.
    • Current treatments are often palliative, especially when underlying diseases cannot be eradicated.

    Purpose of the Study:

    • To review major systemic anti-itch agents.
    • To summarize potential systemic treatments for various types of chronic itch.
    • To provide an overview of therapeutic options for managing pruritus.

    Main Methods:

    • Literature review of systemic anti-itch therapies.
    • Analysis of treatment strategies based on itch etiology.
    • Synthesis of current knowledge on pharmacological interventions for pruritus.

    Main Results:

    • Systemic treatment efficacy varies significantly with the cause of chronic itch.
    • Identifying and treating the underlying etiology is crucial for effective itch management.
    • A range of systemic agents can be considered for different pruritic conditions.

    Conclusions:

    • Effective management of chronic itch requires addressing its root causes.
    • Systemic therapies offer diverse options for treating various types of itch.
    • Further research into targeted systemic treatments is warranted to improve patient care.